eIF3a‐PPP2R5A‐mediated ATM/ATR dephosphorylation is essential for irinotecan‐induced DNA damage response-Reference-Cited by-同舟云学术

eIF3a‐PPP2R5A‐mediated ATM/ATR dephosphorylation is essential for irinotecan‐induced DNA damage response

Published:2022-02-21 Issue:4 Volume:55 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Proliferation

Author:

Mei Chao¹²,Sun Ze‐En¹²,Tan Li‐Ming³,Gong Jian‐Ping³,Li Xi¹²,Liu Zhao‐Qian¹²^ORCID

Affiliation:

1. Department of Clinical Pharmacology Hunan Key Laboratory of Pharmacogenetics National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha China

2. Institute of Clinical Pharmacology Engineering Research Center for Applied Technology of Pharmacogenomics of Ministry of Education Central South University Changsha China

3. Department of Pharmacy The Second People’s Hospital of Huaihua City Huaihua China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13208

Reference39 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?;Li F;Am J Cancer Res,2017

3. Irinotecan pharmacokinetics;Chabot GG;Bull Cancer,1998

4. Recent developments in topoisomerase-targeted cancer chemotherapy

5. The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIRT2 promotes base excision repair by transcriptionally activating OGG1 in an ATM/ATR-dependent manner;Nucleic Acids Research;2024-03-30

2. TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer;Cellular Oncology;2023-11-16

3. A carrier-free supramolecular nano-twin-drug for overcoming irinotecan-resistance and enhancing efficacy against colorectal cancer;Journal of Nanobiotechnology;2023-10-28

4. TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer;2023-09-04

5. A Carrier-Free Supramolecular Nano-Twin-Drug for Overcoming Irinotecan- Resistance and Enhancing Efficacy against Colorectal Cancer;2023-08-17